Here's what to expect from ERYTECH PHARMA (spons ADRs)'s earnings

ERYTECH PHARMA (spons ADRs) is reporting earnings from Q2 on September 21.

Wall Street analysts are expecting losses per share ofA $0.659.

Go here to follow ERYTECH PHARMA (spons ADRs) stock price in real-time on Markets Insider.

On September 21, ERYTECH PHARMA (spons ADRs) will release figures for Q2.In terms of EPS, 1 analyst is predicting losses of $0.659 per share as opposed to losses of $1.080 per share in the same quarter of the previous year.Wall Street is expecting $1.1 million, an decrease of 53.09% over the prior year quarter.Overall, analysts expect an average loss of $2.740 per share for the current fiscal year, compared to $-3.896 per share in the previous year. On average, analysts predict that the company will report annual sales of $4.5 million.This story was written by Markets Insider's RoboEddy, which automatically writes these stories based on data provided by our partners.
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Январь 2021    »